摘要
目的观察依达拉奉对急性脑梗死的临床疗效。方法治疗组48例,在常规治疗的基础上加用依达拉奉治疗,对照组48例,仅用常规治疗方法。两组在治疗前、后14天分别进行神经功能缺损评分(ESS)和日常生活能力缺陷评分(ADL),同时两组均进行临床疗效评定。结果治疗组于治疗后ESS评分为(79.35±17.96)分、ADL评分为(73.02±25.60)分,均高于列照组(P<0.05);治疗组的显效率和有效率分别为47.91%和95.83%,显著高于对照组的20.83%和72.91%(P<0.05)。结论依达拉奉能有效改善急性脑梗死患者的神经功能缺失和日常生活能力。
Objective To investigate the clinical therapeutic effect of edaravone on acute cerebral infarction. Methods There were 48 cases in the treatment group; they were treated with the conventional therapy plus edaravone. 48 cases in the control group were treated only with conventional therapy. On the fourteenth day the two groups were evaluated by neurological deficit score and score of activities of daily living(ADL); the therapeutic effects of both groups were evaluated too. Results The neurological deficit score in the treatment group was 79.35±17.96; score of ADL was 73.02±25.60; the two sorts of score were higher than in the control group. The excellent rate and effective rate were 47.91% and 95.83% respectively; the excellent rate and effective rate in the control group were 20.83% and 72.91% (P<0.05). Conclusion Edaravone can effectively improve the neurological function deficit and daily living ability of patients with acute cerebral infarction.
出处
《神经病学与神经康复学杂志》
2006年第1期5-7,共3页
Journal of Neurology and Neurorehabilitation
关键词
急性脑梗死
依达拉奉
临床疗效
acute cerebral infarction
edaravone
clinical therapeutic effect